rs112762

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000610.4(CD44):​c.68-5493C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.557 in 152,048 control chromosomes in the GnomAD database, including 24,487 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).

Frequency

Genomes: 𝑓 0.56 ( 24487 hom., cov: 33)

Consequence

CD44
NM_000610.4 intron

Scores

3

Clinical Significance

association no assertion criteria provided O:1

Conservation

PhyloP100: -0.163

Publications

7 publications found
Variant links:
Genes affected
CD44 (HGNC:1681): (CD44 molecule (IN blood group)) The protein encoded by this gene is a cell-surface glycoprotein involved in cell-cell interactions, cell adhesion and migration. It is a receptor for hyaluronic acid (HA) and can also interact with other ligands, such as osteopontin, collagens, and matrix metalloproteinases (MMPs). This protein participates in a wide variety of cellular functions including lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis. Transcripts for this gene undergo complex alternative splicing that results in many functionally distinct isoforms, however, the full length nature of some of these variants has not been determined. Alternative splicing is the basis for the structural and functional diversity of this protein, and may be related to tumor metastasis. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000610.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.691 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000610.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD44
NM_000610.4
MANE Select
c.68-5493C>T
intron
N/ANP_000601.3
CD44
NM_001440324.1
c.68-5493C>T
intron
N/ANP_001427253.1
CD44
NM_001440325.1
c.68-5493C>T
intron
N/ANP_001427254.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD44
ENST00000428726.8
TSL:1 MANE Select
c.68-5493C>T
intron
N/AENSP00000398632.2P16070-1
CD44
ENST00000415148.6
TSL:1
c.68-5493C>T
intron
N/AENSP00000389830.2P16070-4
CD44
ENST00000433892.6
TSL:1
c.68-5493C>T
intron
N/AENSP00000392331.2P16070-10

Frequencies

GnomAD3 genomes
AF:
0.557
AC:
84564
AN:
151930
Hom.:
24435
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.697
Gnomad AMI
AF:
0.514
Gnomad AMR
AF:
0.587
Gnomad ASJ
AF:
0.517
Gnomad EAS
AF:
0.308
Gnomad SAS
AF:
0.538
Gnomad FIN
AF:
0.440
Gnomad MID
AF:
0.551
Gnomad NFE
AF:
0.505
Gnomad OTH
AF:
0.566
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.557
AC:
84686
AN:
152048
Hom.:
24487
Cov.:
33
AF XY:
0.554
AC XY:
41180
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.698
AC:
28921
AN:
41462
American (AMR)
AF:
0.588
AC:
8985
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.517
AC:
1791
AN:
3466
East Asian (EAS)
AF:
0.307
AC:
1591
AN:
5174
South Asian (SAS)
AF:
0.538
AC:
2592
AN:
4818
European-Finnish (FIN)
AF:
0.440
AC:
4647
AN:
10566
Middle Eastern (MID)
AF:
0.565
AC:
166
AN:
294
European-Non Finnish (NFE)
AF:
0.505
AC:
34324
AN:
67958
Other (OTH)
AF:
0.568
AC:
1200
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1896
3791
5687
7582
9478
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
724
1448
2172
2896
3620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.448
Hom.:
1805
Bravo
AF:
0.570
Asia WGS
AF:
0.465
AC:
1616
AN:
3478

ClinVar

ClinVar submissions
Significance:association
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
-
Nephrolithiasis, calcium oxalate (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.1
DANN
Benign
0.35
PhyloP100
-0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs112762;
hg19: chr11-35192629;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.